Beijing Tiantan Biological Products Corporation Limited’s Net Profit Rose 12.7% in 2022

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 1.2 billion yuan in 2022, up 12.7% year-on-year.

Meanwhile, the company posted 4.3 billion yuan in revenue, up 3.6% year-on-year.

At the end of the reporting period, it had 12.9 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 12.2%.